Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Glioma · Glioblastoma Multiforme

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Joon Uhm, MD) · uhm.joon@mayo.edu · 507-284-2120
University of Nebraska Medical Center, Omaha, Nebraska, United States
Contact: Study coordinator (Nicole Shonka, MD) · nshonka@unmc.edu · 402-559-3881

Study leads

Nicole Shonka, MD
Principal Investigator
University of Nebraska
Joon Uhm, MD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Anaplastic Astrocytoma, IDH-Wildtype · Anaplastic Oligoastrocytoma · Anaplastic Oligodendroglioma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM

Abroad (travel likely)RecruitingPHASE2

Springdale, United States · Los Angeles, United States

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States